187 related articles for article (PubMed ID: 10368043)
1. Second non-germ cell malignancies in patients treated for stage I-II testicular seminoma.
Bachaud JM; Berthier F; Soulié M; Malavaud B; Plante P; Rischmann P; Chevreau C; Daly-Schveitzer N; Grosclaude P
Radiother Oncol; 1999 Feb; 50(2):191-7. PubMed ID: 10368043
[TBL] [Abstract][Full Text] [Related]
2. [Risk of second non-germ cell cancer after treatment of stage I-II testicular seminoma].
Bachaud JM; Berthier F; Soulié M; Malavaud B; Plante P; Rischmann P; Chevreau C; Grosclaude P
Prog Urol; 1999 Sep; 9(4):689-95. PubMed ID: 10555222
[TBL] [Abstract][Full Text] [Related]
3. Long-term outcomes of radiotherapy for stage II testicular seminoma--the Mayo Clinic experience.
Hallemeier CL; Pisansky TM; Davis BJ; Choo R
Urol Oncol; 2013 Nov; 31(8):1832-8. PubMed ID: 22537538
[TBL] [Abstract][Full Text] [Related]
4. Management of testicular seminoma advanced disease. Report on 14 cases and review of the literature.
Porcaro AB; Antoniolli SZ; Maffei N; Beltrami P; Bassetto MA; Curti P
Arch Ital Urol Androl; 2002 Jun; 74(2):81-5. PubMed ID: 12161942
[TBL] [Abstract][Full Text] [Related]
5. Secondary malignancy among seminoma patients treated with adjuvant radiation therapy.
Chao CK; Lai PP; Michalski JM; Perez CA
Int J Radiat Oncol Biol Phys; 1995 Nov; 33(4):831-5. PubMed ID: 7591890
[TBL] [Abstract][Full Text] [Related]
6. Combination carboplatin and radiotherapy in the management of stage II testicular seminoma: comparison with radiotherapy treatment alone.
Patterson H; Norman AR; Mitra SS; Nicholls J; Fisher C; Dearnaley DP; Horwich A; Mason MD; Huddart RA
Radiother Oncol; 2001 Apr; 59(1):5-11. PubMed ID: 11295200
[TBL] [Abstract][Full Text] [Related]
7. Adverse effects after radiotherapy for early stage (I,IIa,IIb) seminoma.
Majewski W; Majewski S; Maciejewski A; Kolosza Z; Tarnawski R
Radiother Oncol; 2005 Sep; 76(3):257-63. PubMed ID: 15921773
[TBL] [Abstract][Full Text] [Related]
8. Interdisciplinary evidence-based recommendations for the follow-up of early stage seminomatous testicular germ cell cancer patients.
Souchon R; Hartmann M; Krege S; Lorch A; Mayer F; De Santis M; Gillessen S; Beyer J; Cathomas R
Strahlenther Onkol; 2011 Mar; 187(3):158-66. PubMed ID: 21347634
[TBL] [Abstract][Full Text] [Related]
9. Second primary cancer in irradiated stage I testicular seminoma.
Stein ME; Steiner M; Lachter J; Kessel I; Moskovitz B; Kuten A
Strahlenther Onkol; 1993 Nov; 169(11):672-7. PubMed ID: 8248844
[TBL] [Abstract][Full Text] [Related]
10. Late gastrointestinal morbidity in patients with stage I-II testicular seminoma treated with radiotherapy.
Hallemeier CL; Davis BJ; Pisansky TM; Choo R
Urol Oncol; 2014 May; 32(4):496-500. PubMed ID: 24332645
[TBL] [Abstract][Full Text] [Related]
11. [Urologic treatment of testicular germ cell cancer].
Fernández Gómez JM; Escaf Barmadah S; Guate Ortiz JL; Martín Huescar A; Fresno Forcelledo F; García Rodríguez J; Rodríguez Faba O; Jalón Monzón A; Rodríguez Martínez JJ
Arch Esp Urol; 2002 Oct; 55(8):927-36. PubMed ID: 12455283
[TBL] [Abstract][Full Text] [Related]
12. Stage II Testicular Seminoma: Patterns of Care and Survival by Treatment Strategy.
Glaser SM; Vargo JA; Balasubramani GK; Beriwal S
Clin Oncol (R Coll Radiol); 2016 Aug; 28(8):513-21. PubMed ID: 27146264
[TBL] [Abstract][Full Text] [Related]
13. Predicted rates of secondary malignancies from proton versus photon radiation therapy for stage I seminoma.
Simone CB; Kramer K; O'Meara WP; Bekelman JE; Belard A; McDonough J; O'Connell J
Int J Radiat Oncol Biol Phys; 2012 Jan; 82(1):242-9. PubMed ID: 21236595
[TBL] [Abstract][Full Text] [Related]
14. Management of stage II seminoma.
Warde P; Gospodarowicz M; Panzarella T; Catton C; Sturgeon J; Moore M; Jewett M
J Clin Oncol; 1998 Jan; 16(1):290-4. PubMed ID: 9440755
[TBL] [Abstract][Full Text] [Related]
15. Radiotherapy or chemotherapy for clinical stage IIA and IIB seminoma: a systematic review and meta-analysis of patient outcomes.
Giannatempo P; Greco T; Mariani L; Nicolai N; Tana S; Farè E; Raggi D; Piva L; Catanzaro M; Biasoni D; Torelli T; Stagni S; Avuzzi B; Maffezzini M; Landoni G; De Braud F; Gianni AM; Sonpavde G; Salvioni R; Necchi A
Ann Oncol; 2015 Apr; 26(4):657-668. PubMed ID: 25214543
[TBL] [Abstract][Full Text] [Related]
16. Second malignancies following pure seminoma.
Rüther U; Dieckmann KP; Bussar-Maatz R; Eisenberger F
Oncology; 2000; 58(1):75-82. PubMed ID: 10644944
[TBL] [Abstract][Full Text] [Related]
17. Incidence of second malignancies after external beam radiotherapy for clinical stage I testicular seminoma.
Lewinshtein D; Gulati R; Nelson PS; Porter CR
BJU Int; 2012 Mar; 109(5):706-12. PubMed ID: 21883828
[TBL] [Abstract][Full Text] [Related]
18. Long-term results in patients affected by testicular seminoma treated with radiotherapy: risk of second malignancies.
Fatigante L; Ducci F; Campoccia S; Nocita AM; Paci E; Crocetti E; Cionini L
Tumori; 2005; 91(2):144-50. PubMed ID: 15948542
[TBL] [Abstract][Full Text] [Related]
19. Risks of second malignancies after breast cancer treatment: Long-term results.
Bazire L; De Rycke Y; Asselain B; Fourquet A; Kirova YM
Cancer Radiother; 2017 Feb; 21(1):10-15. PubMed ID: 28034681
[TBL] [Abstract][Full Text] [Related]
20. Management of clinical stage I testicular pure seminoma. Report on 42 patients and review of the literature.
Porcaro AB; Antoniolli SZ; Schiavone D; Maffei N; Bassetto MA; Curti P
Arch Ital Urol Androl; 2002 Jun; 74(2):77-80. PubMed ID: 12161941
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
